Atlas Trials

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

Clinical trial NCT07254754 · RECRUITING

Trial details

NCT number
NCT07254754
Sponsor
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DIFFUSE LARGE B-CELL LYMPHOMA
Start date
2024-11-20
Primary completion
2027-01-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.